ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Cardiovascular Systems, Inc. CSII recently announced an acquisition option agreement with Chansu Vascular Technologies, LLC (CVT) for the development of a peripheral everolimus drug-coated balloon ...
With the help of a small California startup, Cardiovascular Systems has laid out plans to build a full portfolio of minimally invasive medical hardware designed to remove blood clots. The devicemaker ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Illinois-based medical technology giant Abbott will acquire New Brighton-based medical device company Cardiovascular Systems Inc., the companies announced Wednesday. Under the terms of the agreement, ...
Cardiovascular disease is the leading cause of death in the United States, claiming an estimated 1 million lives, and incurring a cost of $400 billion per year. Much of cardiovascular disease can be ...
The Molecular Physiology of the Cardiovascular System training program is a multi-disciplinary training program for pre- and postdoctoral trainees. The goal of our program is to train students and ...
A tool like a tiny orbital sander is the heart of the Diamondback 360° system, a medical device that removes plaque from the walls of arteries in the leg. It’s the flagship product of Cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results